Browsing Tag
mesothelioma
7 posts
How oral Targeted Glue degraders could change dosing paradigms in cancer treatment
Discover how oral Targeted Glue degraders could transform cancer dosing strategies and reshape oncology treatment models. Read the full analysis.
Can ODM-212 validate TEAD inhibition as a viable oncology strategy in mesothelioma?
Can Orion Corporation’s ODM-212 prove TEAD inhibition works in mesothelioma? Discover what this FDA orphan designation really signals.
Inside Johnson & Johnson’s $966m talc verdict: how one case could reshape its future battles
Find out how Johnson & Johnson’s $966 million talc cancer verdict could reshape its litigation strategy, investor sentiment, and brand credibility.
Jury awards $45m in damages in asbestos-related lawsuit against Johnson & Johnson
In a landmark decision, the Circuit Court of Cook County in Chicago has found Johnson & Johnson (NYSE:…
Ikena Oncology gets FDA fast track designation for IK-930 in mesothelioma
Ikena Oncology has secured fast track designation for IK-930 from the US Food and Drug Administration in the…
TCR2 Therapeutics reports positive interim results for gavo-cel in early-stage solid tumors trial
TCR2 Therapeutics has reported positive interim results from its phase 1 part of the phase 1/2 clinical trial…
Zydus Cadila gets FDA nod for chemotherapy drug Pemetrexed generic
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food…